A Mechanical Immune Checkpoint Inhibitor Stiffens Tumor Cells to Potentiate Antitumor Immunity
Yu Zhao(Nankai University), Fan Huang(Anhui Medical University), Qingqing Huang(Shanghai University of Medicine and Health Sciences), Xiaoxue Hou(Chinese Academy of Medical Sciences & Peking Union Medical College), Yufei Ma(Chongqing Institute of Green and Intelligent Technology), Linqi Shi(Nankai University), Zeyu Wang(Anhui University), Yuanfeng Li(Wenzhou Medical University), Chunxiong Zheng(South China Normal University), Yong Liu(Tango Therapeutics (United States)), Yang Liu(Nankai University), Shiyu Peng(Westlake University)
Cited by 4
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer
|Journal of Hepatology|2021|215
Biomedical polymers: synthesis, properties, and applications
|Science China Chemistry|2022|192